Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	K63-linked polyubiquitin modification-dependent protein binding	IKBKG TNFAIP3 ZRANB3	1.15e-04	26	73	3	GO:0070530
GeneOntologyMolecularFunction	neuregulin binding	ERBB3 ITGB3	1.96e-04	6	73	2	GO:0038132
GeneOntologyMolecularFunction	ubiquitin-protein transferase activity	CUL5 TRIM49 TRIM51 TRIM49C TNFAIP3 RFPL1 RFPL3 RFPL2	3.26e-04	473	73	8	GO:0004842
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	CUL5 TRIM49 TRIM51 TRIM49C TNFAIP3 RFPL1 RFPL3 RFPL2	5.51e-04	512	73	8	GO:0019787
GeneOntologyMolecularFunction	aminoacyltransferase activity	CUL5 TRIM49 TRIM51 TRIM49C TNFAIP3 RFPL1 RFPL3 RFPL2	7.08e-04	532	73	8	GO:0016755
GeneOntologyMolecularFunction	kinase binding	CDK9 TRIM49 TRIM51 EGFR POLA1 TRIM49C TNFAIP3 RFPL1 ITGB3 RFPL3 RFPL2	7.48e-04	969	73	11	GO:0019900
GeneOntologyMolecularFunction	insulin-like growth factor I binding	LRP2 ITGB3	1.00e-03	13	73	2	GO:0031994
GeneOntologyMolecularFunction	protein kinase binding	CDK9 TRIM49 TRIM51 EGFR POLA1 TRIM49C RFPL1 ITGB3 RFPL3 RFPL2	1.24e-03	873	73	10	GO:0019901
GeneOntologyMolecularFunction	polyubiquitin modification-dependent protein binding	IKBKG TNFAIP3 ZRANB3	1.32e-03	59	73	3	GO:0031593
GeneOntologyMolecularFunction	zinc ion binding	PAPPA2 TRIM49 USP49 TRIM51 ADAMTS9 POLA1 ESRRB TRIM49C TNFAIP3 ZRANB3	1.44e-03	891	73	10	GO:0008270
GeneOntologyMolecularFunction	insulin-like growth factor binding	LRP2 ITGB3	2.17e-03	19	73	2	GO:0005520
GeneOntologyMolecularFunction	coreceptor activity	GPC4 GPC6 ITGB3	2.33e-03	72	73	3	GO:0015026
GeneOntologyMolecularFunction	ubiquitin protein ligase activity	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	2.39e-03	372	73	6	GO:0061630
GeneOntologyMolecularFunction	growth factor binding	ERBB3 EGFR LRP2 ITGB3	2.57e-03	156	73	4	GO:0019838
GeneOntologyCellularComponent	microfibril	THSD4 FBN1 FBN3	1.24e-05	13	75	3	GO:0001527
GeneOntologyCellularComponent	female germ cell nucleus	RFPL1 RFPL3 RFPL2	1.85e-04	31	75	3	GO:0001674
MousePheno	abnormal aortic sinus morphology	THSD4 FBN1	1.69e-05	2	58	2	MP:0010482
MousePheno	abnormal skin appearance	CUL5 PDS5B FBN1 PNPLA6 EGFR FSHR IKBKG GRN ITGB3 PROS1	2.17e-05	473	58	10	MP:0009931
MousePheno	absent cerebellum vermis	ERBB3 ZNF423	5.06e-05	3	58	2	MP:0000865
MousePheno	abnormal cerebellar plate morphology	ERBB3 ZNF423	5.06e-05	3	58	2	MP:0000856
MousePheno	abnormal trophoblast giant cell morphology	PNPLA6 EGFR ESRRB TRRAP ITGB3	7.59e-05	106	58	5	MP:0005033
MousePheno	abnormal mural trophectoderm morphology	PNPLA6 EGFR ESRRB TRRAP ITGB3	7.94e-05	107	58	5	MP:0012057
MousePheno	abnormal hindlimb morphology	PAPPA2 FLNC FBN1 HOXC10 SCUBE2 ACADM EGFR FSHR TSHR GPC6	1.14e-04	576	58	10	MP:0000556
MousePheno	abnormal respiration	PDS5B FLNC TSHZ3 ERBB3 FBN1 EGFR SFTPC FAT3 ISM1 LRP2	1.55e-04	598	58	10	MP:0001943
MousePheno	cardiac valve regurgitation	ERBB3 FBN1 EGFR	1.65e-04	26	58	3	MP:0009384
MousePheno	decreased femur size	PAPPA2 HOXC10 SCUBE2 FSHR GPC6	1.99e-04	130	58	5	MP:0030825
MousePheno	abnormal skin morphology	CUL5 PDS5B ENKUR FBN1 PNPLA6 EGFR ADAMTS9 OTOGL FAT3 FSHR MAP3K9 IKBKG GRN TNFAIP3 ITGB3 PROS1	2.01e-04	1455	58	16	MP:0002060
MousePheno	abnormal femur morphology	PAPPA2 HOXC10 SCUBE2 FSHR TSHR GPC6	2.50e-04	214	58	6	MP:0000559
MousePheno	increased thyrotroph cell number	FSHR TSHR	2.51e-04	6	58	2	MP:0008337
MousePheno	uterine hemorrhage	FSHR ITGB3	2.51e-04	6	58	2	MP:0004898
MousePheno	abnormal heart valve physiology	ERBB3 FBN1 EGFR	2.54e-04	30	58	3	MP:0011926
MousePheno	abnormal uterus physiology	FSHR TNFAIP3 ITGB3	2.54e-04	30	58	3	MP:0009671
MousePheno	abnormal vagina orifice morphology	EGFR FSHR LRP2	2.54e-04	30	58	3	MP:0001142
MousePheno	abnormal hindlimb stylopod morphology	PAPPA2 HOXC10 SCUBE2 FSHR TSHR GPC6	2.57e-04	215	58	6	MP:0003856
MousePheno	abnormal extraembryonic tissue morphology	FLNC NANOGP8 FBN1 PNPLA6 EGFR ADAMTS9 ESRRB LRP2 TRRAP ITGB3 ZFY PROS1	2.90e-04	908	58	12	MP:0002086
MousePheno	abnormal uterine environment	FSHR TSHR ITGB3	4.04e-04	35	58	3	MP:0004014
MousePheno	abnormal telencephalon morphology	ZNF597 ERBB3 EGFR ZNF423 FSHR LRP2 GRN POGZ SSPOP WDR62 PROS1	4.38e-04	812	58	11	MP:0000787
MousePheno	abnormal cartilage morphology	FBN1 HOXC10 SCUBE2 EGFR KIAA1217 TSHR GPC6	4.57e-04	336	58	7	MP:0000163
MousePheno	overexpanded pulmonary alveolus	FBN1 SFTPC LRP2	4.76e-04	37	58	3	MP:0001183
MousePheno	emphysema	FBN1 SFTPC LRP2	4.76e-04	37	58	3	MP:0001958
MousePheno	limbs/digits/tail phenotype	PAPPA2 PDS5B FLNC FBN1 HOXC10 SCUBE2 ACADM EGFR ADAMTS9 KIAA1217 FSHR LRP2 TSHR GPC6	4.93e-04	1258	58	14	MP:0005371
MousePheno	abnormal limb long bone morphology	PAPPA2 PDS5B FBN1 HOXC10 SCUBE2 ACADM FSHR TSHR GPC6	5.09e-04	568	58	9	MP:0011504
MousePheno	abnormal trophectoderm morphology	PNPLA6 EGFR ESRRB TRRAP ITGB3	5.18e-04	160	58	5	MP:0005028
MousePheno	abnormal aorta tunica media morphology	THSD4 FBN1 ACADM	5.57e-04	39	58	3	MP:0009873
MousePheno	abnormal aorta bulb morphology	THSD4 FBN1	5.98e-04	9	58	2	MP:0011572
MousePheno	absent nasal septum	LRP2 GPC6	5.98e-04	9	58	2	MP:0004872
MousePheno	short radius	PAPPA2 PDS5B FBN1	6.01e-04	40	58	3	MP:0004355
MousePheno	decreased radius size	PAPPA2 PDS5B FBN1	6.01e-04	40	58	3	MP:0030886
MousePheno	abnormal limb bone morphology	PAPPA2 PDS5B FBN1 HOXC10 SCUBE2 ACADM FSHR TSHR GPC6	6.45e-04	587	58	9	MP:0002115
MousePheno	decreased respiration	FLNC ERBB3 FBN1 EGFR LRP2	6.83e-04	170	58	5	MP:0014274
MousePheno	abnormal blastocyst morphology	NANOGP8 PNPLA6 EGFR ESRRB TRRAP ITGB3	6.90e-04	259	58	6	MP:0004957
MousePheno	abnormal epidermal pigmentation	ADAMTS9 IKBKG	7.45e-04	10	58	2	MP:0009387
MousePheno	abnormal cerebral hemisphere morphology	ERBB3 EGFR ZNF423 FSHR LRP2 GRN POGZ WDR62 PROS1	7.46e-04	599	58	9	MP:0008540
MousePheno	abnormal parietal yolk sac morphology	PNPLA6 EGFR ESRRB TRRAP ITGB3	8.19e-04	177	58	5	MP:0011203
MousePheno	short ulna	PAPPA2 PDS5B FBN1	9.07e-04	46	58	3	MP:0004359
MousePheno	decreased ulna size	PAPPA2 PDS5B FBN1	9.07e-04	46	58	3	MP:0030900
MousePheno	petechiae	EGFR ITGB3	9.08e-04	11	58	2	MP:0008816
MousePheno	abnormal thrombosis	FBN1 FSHR ITGB3 PROS1	9.68e-04	106	58	4	MP:0005048
MousePheno	abnormal interleukin-6 secretion	CUL5 USP49 IKBKG GRN TNFAIP3	1.02e-03	186	58	5	MP:0008704
MousePheno	abnormal choroid plexus morphology	ERBB3 ZNF423 LRP2	1.03e-03	48	58	3	MP:0000820
MousePheno	abnormal tela choroidea morphology	ERBB3 ZNF423 LRP2	1.03e-03	48	58	3	MP:0013306
MousePheno	abnormal neocortex morphology	ERBB3 WDR62 PROS1	1.03e-03	48	58	3	MP:0008547
MousePheno	internal hemorrhage	FBN1 PNPLA6 FSHR MAP3K9 IKBKG ITGB3 PROS1	1.05e-03	387	58	7	MP:0001634
MousePheno	abnormal preimplantation embryo morphology	NANOGP8 PNPLA6 EGFR ESRRB TRRAP ITGB3	1.09e-03	283	58	6	MP:0014137
MousePheno	abnormal circulating progesterone level	FSHR TSHR TNFAIP3	1.16e-03	50	58	3	MP:0005184
MousePheno	abnormal aorta wall morphology	THSD4 FBN1 ACADM	1.16e-03	50	58	3	MP:0009866
Domain	Growth_fac_rcpt_	ELAPOR2 ERBB3 FBN1 SCUBE2 EGFR LRP2 FBN3 PROS1	1.87e-07	156	74	8	IPR009030
Domain	ConA-like_dom	PAPPA2 TRIM49 TRIM51 FAT3 TRIM49C RFPL1 RFPL3 RFPL2 PROS1	2.03e-07	219	74	9	IPR013320
Domain	Butyrophylin	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	3.38e-07	70	74	6	IPR003879
Domain	RDM	RFPL1 RFPL3 RFPL2	5.94e-07	5	74	3	PF11002
Domain	RDM_domain_RFPL	RFPL1 RFPL3 RFPL2	5.94e-07	5	74	3	IPR022723
Domain	EGF_1	FBN1 SCUBE2 FAT3 LRP2 C7 SSPOP ITGB3 FBN3 PROS1	7.30e-07	255	74	9	PS00022
Domain	EGF_2	FBN1 SCUBE2 FAT3 LRP2 C7 SSPOP ITGB3 FBN3 PROS1	1.01e-06	265	74	9	PS01186
Domain	EGF_CA	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	1.15e-06	86	74	6	PF07645
Domain	SPRY	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	1.95e-06	94	74	6	PF00622
Domain	SPRY_dom	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	1.95e-06	94	74	6	IPR003877
Domain	B30.2/SPRY	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	2.07e-06	95	74	6	IPR001870
Domain	B302_SPRY	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	2.07e-06	95	74	6	PS50188
Domain	EGF_Ca-bd_CS	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	2.34e-06	97	74	6	IPR018097
Domain	EGF_CA	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	2.64e-06	99	74	6	PS01187
Domain	ASX_HYDROXYL	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	2.79e-06	100	74	6	PS00010
Domain	cEGF	FBN1 SCUBE2 LRP2 FBN3	3.18e-06	26	74	4	IPR026823
Domain	cEGF	FBN1 SCUBE2 LRP2 FBN3	3.18e-06	26	74	4	PF12662
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	3.93e-06	106	74	6	IPR000152
Domain	EGF_3	FBN1 SCUBE2 FAT3 LRP2 C7 SSPOP FBN3 PROS1	4.11e-06	235	74	8	PS50026
Domain	TSP_1	THSD4 ADAMTS9 ISM1 C7 SSPOP	5.00e-06	63	74	5	PF00090
Domain	TSP1	THSD4 ADAMTS9 ISM1 C7 SSPOP	5.84e-06	65	74	5	SM00209
Domain	TSP1_rpt	THSD4 ADAMTS9 ISM1 C7 SSPOP	5.84e-06	65	74	5	IPR000884
Domain	TSP1	THSD4 ADAMTS9 ISM1 C7 SSPOP	5.84e-06	65	74	5	PS50092
Domain	EGF_CA	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	8.85e-06	122	74	6	SM00179
Domain	EGF-like_CS	FBN1 SCUBE2 FAT3 LRP2 C7 ITGB3 FBN3 PROS1	8.88e-06	261	74	8	IPR013032
Domain	EGF-like_Ca-bd_dom	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	9.71e-06	124	74	6	IPR001881
Domain	SPRY	TRIM49 TRIM49C RFPL1 RFPL3 RFPL2	2.44e-05	87	74	5	SM00449
Domain	FBN	FBN1 FBN3	4.63e-05	3	74	2	IPR011398
Domain	EGF-like_dom	FBN1 SCUBE2 FAT3 LRP2 C7 FBN3 PROS1	5.79e-05	249	74	7	IPR000742
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB3 EGFR	9.24e-05	4	74	2	IPR016245
Domain	EGF	SCUBE2 LRP2 ITGB3 FBN3 PROS1	1.43e-04	126	74	5	PF00008
Domain	GLYPICAN	GPC4 GPC6	2.30e-04	6	74	2	PS01207
Domain	Glypican	GPC4 GPC6	2.30e-04	6	74	2	IPR001863
Domain	GF_recep_IV	ERBB3 EGFR	2.30e-04	6	74	2	PF14843
Domain	GF_recep_IV	ERBB3 EGFR	2.30e-04	6	74	2	IPR032778
Domain	Glypican	GPC4 GPC6	2.30e-04	6	74	2	PF01153
Domain	Gphrmn_rcpt_fam	FSHR TSHR	2.30e-04	6	74	2	IPR002131
Domain	Glypican_CS	GPC4 GPC6	2.30e-04	6	74	2	IPR019803
Domain	Furin-like	ERBB3 EGFR	3.21e-04	7	74	2	PF00757
Domain	Rcpt_L-dom	ERBB3 EGFR	3.21e-04	7	74	2	IPR000494
Domain	TB	FBN1 FBN3	3.21e-04	7	74	2	PF00683
Domain	Furin-like_Cys-rich_dom	ERBB3 EGFR	3.21e-04	7	74	2	IPR006211
Domain	Recep_L_domain	ERBB3 EGFR	3.21e-04	7	74	2	PF01030
Domain	-	ERBB3 EGFR	3.21e-04	7	74	2	3.80.20.20
Domain	EGF	FBN1 SCUBE2 FAT3 LRP2 FBN3 PROS1	3.38e-04	235	74	6	SM00181
Domain	-	TRIM49 USP49 TRIM51 ZNF423 TRIM49C RFPL1 RFPL3 RFPL2	3.94e-04	449	74	8	3.30.40.10
Domain	-	FBN1 FBN3	4.27e-04	8	74	2	3.90.290.10
Domain	Znf_RING/FYVE/PHD	TRIM49 USP49 TRIM51 ZNF423 TRIM49C RFPL1 RFPL3 RFPL2	4.56e-04	459	74	8	IPR013083
Domain	LDLR_class-A_CS	LRP2 C7 SSPOP	5.31e-04	40	74	3	IPR023415
Domain	TB	FBN1 FBN3	5.48e-04	9	74	2	PS51364
Domain	TB_dom	FBN1 FBN3	5.48e-04	9	74	2	IPR017878
Domain	PRY	RFPL1 RFPL3 RFPL2	6.13e-04	42	74	3	PF13765
Domain	LRR_5	FSHR TSHR	6.83e-04	10	74	2	PF13306
Domain	LRR_5	FSHR TSHR	6.83e-04	10	74	2	IPR026906
Domain	Ldl_recept_a	LRP2 C7 SSPOP	7.52e-04	45	74	3	PF00057
Domain	-	LRP2 C7 SSPOP	8.02e-04	46	74	3	4.10.400.10
Domain	PRY	RFPL1 RFPL3 RFPL2	9.09e-04	48	74	3	SM00589
Domain	LDLRA_1	LRP2 C7 SSPOP	9.09e-04	48	74	3	PS01209
Domain	PRY	RFPL1 RFPL3 RFPL2	9.09e-04	48	74	3	IPR006574
Domain	LDLRA_2	LRP2 C7 SSPOP	9.65e-04	49	74	3	PS50068
Domain	LDrepeatLR_classA_rpt	LRP2 C7 SSPOP	9.65e-04	49	74	3	IPR002172
Domain	LDLa	LRP2 C7 SSPOP	9.65e-04	49	74	3	SM00192
Domain	ZF_RING_1	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	1.04e-03	291	74	6	PS00518
Domain	ZF_RING_2	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	1.17e-03	298	74	6	PS50089
Domain	RING	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	1.32e-03	305	74	6	SM00184
Domain	TIL_dom	LRP2 SSPOP	1.37e-03	14	74	2	IPR002919
Domain	zf-C2H2	ZNF597 TSHZ3 ZNF423 ZKSCAN3 POGZ ZNF30 ZFY ZNF239 ZNF71	1.62e-03	693	74	9	PF00096
Domain	Znf_RING	TRIM49 TRIM51 TRIM49C RFPL1 RFPL3 RFPL2	1.85e-03	326	74	6	IPR001841
Domain	L_dom-like	ERBB3 EGFR FBXL8 FSHR TSHR LRRC74A	1.91e-03	328	74	6	IPR032675
Domain	Furin_repeat	ERBB3 EGFR	2.27e-03	18	74	2	IPR006212
Domain	FU	ERBB3 EGFR	2.27e-03	18	74	2	SM00261
Domain	BBOX	TRIM49 TRIM51 TRIM49C	2.59e-03	69	74	3	SM00336
Domain	-	TRIM49 TRIM51 TRIM49C	2.81e-03	71	74	3	4.10.45.10
Domain	zf-B_box	TRIM49 TRIM51 TRIM49C	2.93e-03	72	74	3	PF00643
Domain	ZINC_FINGER_C2H2_2	ZNF597 TSHZ3 ZNF423 ZKSCAN3 POGZ ZNF30 ZFY ZNF239 ZNF71	3.45e-03	775	74	9	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF597 TSHZ3 ZNF423 ZKSCAN3 POGZ ZNF30 ZFY ZNF239 ZNF71	3.51e-03	777	74	9	PS00028
Domain	ADAM_spacer1	THSD4 ADAMTS9	3.71e-03	23	74	2	IPR010294
Domain	ADAM_spacer1	THSD4 ADAMTS9	3.71e-03	23	74	2	PF05986
Domain	ZF_BBOX	TRIM49 TRIM51 TRIM49C	3.94e-03	80	74	3	PS50119
Pathway	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY	EGFR GPC4 GPC6	8.43e-05	23	53	3	M48234
Pathway	PID_NFKAPPAB_CANONICAL_PATHWAY	IKBKG TNFAIP3 SSPOP	8.43e-05	23	53	3	M37
Pathway	BIOCARTA_ERBB3_PATHWAY	ERBB3 EGFR	1.38e-04	5	53	2	M22018
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	CUL5 ERBB3 EGFR	1.71e-04	29	53	3	M27756
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	THSD4 ADAMTS9 GPC4 GPC6 SSPOP	1.94e-04	143	53	5	M27275
Pathway	BIOCARTA_ERBB3_PATHWAY	ERBB3 EGFR	2.06e-04	6	53	2	MM1543
Pathway	PID_ARF6_PATHWAY	EGFR TSHR ITGB3	3.02e-04	35	53	3	M86
Pathway	REACTOME_DISEASES_OF_METABOLISM	THSD4 ADAMTS9 SFTPC GPC4 GPC6 SSPOP	3.35e-04	250	53	6	M27554
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FBN1 ITGB3 FBN3	3.56e-04	37	53	3	M27134
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD4 ADAMTS9 SSPOP	4.17e-04	39	53	3	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD4 ADAMTS9 SSPOP	4.17e-04	39	53	3	MM15165
Pathway	WP_COMPLEMENT_SYSTEM	LRP2 C7 ITGB3 PROS1	4.58e-04	96	53	4	M39581
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FBN1 ITGB3 FBN3	5.96e-04	44	53	3	M26969
Pathway	REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS	GPC4 LRP2 GPC6	6.37e-04	45	53	3	MM15344
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB3 EGFR	7.46e-04	11	53	2	MM15478
Pathway	REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS	GPC4 LRP2 GPC6	7.70e-04	48	53	3	M27642
Pathway	REACTOME_SIGNALING_BY_ERBB2	CUL5 ERBB3 EGFR	8.68e-04	50	53	3	M553
Pathway	REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS	FSHR TSHR	8.94e-04	12	53	2	M13070
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB3 EGFR	1.05e-03	13	53	2	M27729
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB3 EGFR	1.05e-03	13	53	2	MM15320
Pathway	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY	CUL5 EGFR GPC4 GPC6	1.06e-03	120	53	4	M48233
Pathway	BIOCARTA_CD40_PATHWAY	IKBKG TNFAIP3	1.23e-03	14	53	2	MM1362
Pathway	REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2	GPC4 GPC6	1.23e-03	14	53	2	M27263
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY	EGFR IKBKG	1.23e-03	14	53	2	M47536
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB3 EGFR	1.23e-03	14	53	2	MM14761
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB3 EGFR	1.23e-03	14	53	2	MM14531
Pathway	PID_ERBB_NETWORK_PATHWAY	ERBB3 EGFR	1.41e-03	15	53	2	M201
Pathway	BIOCARTA_CD40_PATHWAY	IKBKG TNFAIP3	1.41e-03	15	53	2	M16697
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB3 EGFR	1.41e-03	15	53	2	M27608
Pathway	REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS	FSHR TSHR	1.41e-03	15	53	2	MM14972
Pathway	WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION	CUL5 IKBKG TNFAIP3	1.55e-03	61	53	3	M42548
Pubmed	Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling.	IKBKG GRN TNFAIP3	9.63e-09	3	75	3	31585000
Pubmed	Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development.	RFPL1 RFPL3 RFPL2	9.63e-09	3	75	3	18656177
Pubmed	Duplications on human chromosome 22 reveal a novel Ret Finger Protein-like gene family with sense and endogenous antisense transcripts.	RFPL1 RFPL3 RFPL2	9.60e-08	5	75	3	10508838
Pubmed	The ret finger protein-like 4 gene, Rfpl4, encodes a putative E3 ubiquitin-protein ligase expressed in adult germ cells.	RFPL1 RFPL3 RFPL2	9.60e-08	5	75	3	11850190
Pubmed	Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.	ERBB3 EGFR SFTPC	3.35e-07	7	75	3	22493501
Pubmed	RFPL4 interacts with oocyte proteins of the ubiquitin-proteasome degradation pathway.	RFPL1 RFPL3 RFPL2	5.35e-07	8	75	3	12525704
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	CDK9 TRIM49 ERBB3 EGFR FBXL8 MAP3K9 TNFAIP3 PRAG1	1.44e-06	372	75	8	22939624
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	ERBB3 EGFR LRP2 TSHR ITGB3	2.75e-06	101	75	5	23382219
Pubmed	Trim43a, Trim43b, and Trim43c: Novel mouse genes expressed specifically in mouse preimplantation embryos.	TRIM49 TRIM51 TRIM49C	4.30e-06	15	75	3	19703589
Pubmed	EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor.	ERBB3 EGFR	4.59e-06	2	75	2	34884742
Pubmed	Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.	FBN1 TNFAIP3	4.59e-06	2	75	2	36289219
Pubmed	ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.	ERBB3 EGFR	4.59e-06	2	75	2	20647770
Pubmed	Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer.	ERBB3 EGFR	4.59e-06	2	75	2	37156315
Pubmed	Thyrostimulin-TSHR signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway.	EGFR TSHR	4.59e-06	2	75	2	27273257
Pubmed	Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors.	ERBB3 EGFR	4.59e-06	2	75	2	26034219
Pubmed	EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis.	ERBB3 EGFR	4.59e-06	2	75	2	27756321
Pubmed	Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.	ERBB3 EGFR	4.59e-06	2	75	2	26844548
Pubmed	Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor.	FSHR TSHR	4.59e-06	2	75	2	25340405
Pubmed	ADAMTSL6β protein rescues fibrillin-1 microfibril disorder in a Marfan syndrome mouse model through the promotion of fibrillin-1 assembly.	THSD4 FBN1	4.59e-06	2	75	2	21880733
Pubmed	Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers.	ERBB3 EGFR	4.59e-06	2	75	2	32080212
Pubmed	EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.	ERBB3 EGFR	4.59e-06	2	75	2	31092882
Pubmed	Epigallocatechin gallate has pleiotropic effects on transmembrane signaling by altering the embedding of transmembrane domains.	EGFR ITGB3	4.59e-06	2	75	2	28487468
Pubmed	Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases.	ERBB3 EGFR	4.59e-06	2	75	2	27872189
Pubmed	An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC.	ERBB3 EGFR	4.59e-06	2	75	2	30302022
Pubmed	Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients.	FBN1 FBN3	4.59e-06	2	75	2	15221638
Pubmed	Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation.	ERBB3 EGFR	4.59e-06	2	75	2	23758840
Pubmed	Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization.	FBN1 ITGB3	4.59e-06	2	75	2	15062093
Pubmed	ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.	ERBB3 EGFR	4.59e-06	2	75	2	17631905
Pubmed	EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer.	ERBB3 EGFR	4.59e-06	2	75	2	20824716
Pubmed	Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines.	ERBB3 EGFR	4.59e-06	2	75	2	28910149
Pubmed	EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT.	ERBB3 EGFR	4.59e-06	2	75	2	10527633
Pubmed	Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments.	ERBB3 EGFR	4.59e-06	2	75	2	25993617
Pubmed	Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis.	ERBB3 EGFR	4.59e-06	2	75	2	27586651
Pubmed	Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer.	ERBB3 EGFR	4.59e-06	2	75	2	24667376
Pubmed	Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis.	ERBB3 EGFR	4.59e-06	2	75	2	26492920
Pubmed	Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.	FBN1 ITGB3	4.59e-06	2	75	2	24107997
Pubmed	ADAMTSL-6 is a novel extracellular matrix protein that binds to fibrillin-1 and promotes fibrillin-1 fibril formation.	THSD4 FBN1	4.59e-06	2	75	2	19940141
Pubmed	Hydrogen bond analysis of the EGFR-ErbB3 heterodimer related to non-small cell lung cancer and drug resistance.	ERBB3 EGFR	4.59e-06	2	75	2	30593826
Pubmed	Lineage-specific biology revealed by a finished genome assembly of the mouse.	TRIM49 TRIM51 TRIM49C FER1L5	6.26e-06	55	75	4	19468303
Pubmed	Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation.	ERBB3 EGFR ADAMTS9	6.41e-06	17	75	3	22183742
Pubmed	Identification of a genomic reservoir for new TRIM genes in primate genomes.	TRIM49 TRIM51 TRIM49C	9.10e-06	19	75	3	22144910
Pubmed	Betacellulin (BTC) Biases the EGFR To Dimerize with ErbB3.	ERBB3 EGFR	1.37e-05	3	75	2	30249613
Pubmed	Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.	ERBB3 EGFR	1.37e-05	3	75	2	17426253
Pubmed	Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.	ERBB3 EGFR	1.37e-05	3	75	2	27070783
Pubmed	Profiling epidermal growth factor receptor and heregulin receptor 3 heteromerization using receptor tyrosine kinase heteromer investigation technology.	ERBB3 EGFR	1.37e-05	3	75	2	23700486
Pubmed	A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.	ERBB3 EGFR	1.37e-05	3	75	2	18632642
Pubmed	ErbB receptor signaling directly controls oligodendrocyte progenitor cell transformation and spontaneous remyelination after spinal cord injury.	ERBB3 EGFR	1.37e-05	3	75	2	30637799
Pubmed	Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.	FSHR TSHR	1.37e-05	3	75	2	11847099
Pubmed	Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.	ERBB3 EGFR	1.37e-05	3	75	2	29138285
Pubmed	Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.	ERBB3 EGFR	1.37e-05	3	75	2	21320340
Pubmed	Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.	FSHR TSHR	1.37e-05	3	75	2	15889138
Pubmed	A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.	ERBB3 EGFR	1.37e-05	3	75	2	28940194
Pubmed	Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors.	GPC4 GPC6	1.37e-05	3	75	2	22722203
Pubmed	Parallel visualization of multiple protein complexes in individual cells in tumor tissue.	ERBB3 EGFR	1.37e-05	3	75	2	23436906
Pubmed	Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation.	ERBB3 EGFR	1.37e-05	3	75	2	11114724
Pubmed	LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival.	ERBB3 EGFR	1.37e-05	3	75	2	33152401
Pubmed	Ligand-induced structural transitions in ErbB receptor extracellular domains.	ERBB3 EGFR	1.37e-05	3	75	2	17697999
Pubmed	Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.	ERBB3 EGFR	1.37e-05	3	75	2	8702572
Pubmed	Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.	ERBB3 EGFR	1.37e-05	3	75	2	18768436
Pubmed	Differential erbB signaling in astrocytes from the cerebral cortex and the hypothalamus of the human brain.	ERBB3 EGFR	1.37e-05	3	75	2	18803307
Pubmed	HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1.	ERBB3 EGFR	1.37e-05	3	75	2	29473311
Pubmed	Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells.	ERBB3 EGFR	1.37e-05	3	75	2	17823122
Pubmed	Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3.	ERBB3 EGFR	1.37e-05	3	75	2	23990774
Pubmed	β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells.	EGFR ITGB3	1.37e-05	3	75	2	21937717
Pubmed	Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.	ERBB3 EGFR	1.37e-05	3	75	2	24014028
Pubmed	Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.	ERBB3 EGFR	1.37e-05	3	75	2	31862538
Pubmed	EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms.	ERBB3 EGFR	1.37e-05	3	75	2	28320942
Pubmed	The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.	ERBB3 EGFR	1.37e-05	3	75	2	28450158
Pubmed	EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.	ERBB3 EGFR	1.37e-05	3	75	2	35902718
Pubmed	[Correlation of epidermal growth factor receptor mutations and HER2/3 protein expression with clinical outcome in advanced non-small cell lung cancer patients treated with gefitinib].	ERBB3 EGFR	1.37e-05	3	75	2	20038315
Pubmed	A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.	IKBKG TNFAIP3	1.37e-05	3	75	2	19494296
Pubmed	EGFR/ERBB receptors differentially modulate sebaceous lipogenesis.	ERBB3 EGFR	1.37e-05	3	75	2	25889637
Pubmed	The immunoexpression of EGFR, HER2 and HER3 in malignant serous ovarian tumors.	ERBB3 EGFR	1.37e-05	3	75	2	29556616
Pubmed	Mechanotransduction in lymphatic endothelial cells.	FBN1 ITGB3	1.37e-05	3	75	2	18062611
Pubmed	Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions.	FSHR TSHR	1.37e-05	3	75	2	8747461
Pubmed	Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins.	EGFR ITGB3	1.37e-05	3	75	2	18375753
Pubmed	Expression of activated type I receptor tyrosine kinases in early breast cancer.	ERBB3 EGFR	1.37e-05	3	75	2	22562124
Pubmed	EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.	ERBB3 EGFR	1.37e-05	3	75	2	21109951
Pubmed	Progranulin expression in breast cancer with different intrinsic subtypes.	EGFR GRN	1.37e-05	3	75	2	22397762
Pubmed	HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells.	ERBB3 EGFR	1.37e-05	3	75	2	19878579
Pubmed	Chronic β-adrenergic stimulation increases ErbB receptors and cell proliferation in mouse kidney.	ERBB3 EGFR	1.37e-05	3	75	2	21554097
Pubmed	Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity.	ERBB3 EGFR	1.37e-05	3	75	2	19060928
Pubmed	m6A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling.	HOXC10 EGFR	1.37e-05	3	75	2	38063205
Pubmed	Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.	ERBB3 EGFR	1.37e-05	3	75	2	18398842
Pubmed	The involvement of EGFR, HER2 and HER3 in the basal cell carcinomas aggressiveness.	ERBB3 EGFR	1.37e-05	3	75	2	30173251
Pubmed	Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.	IKBKG TNFAIP3	1.37e-05	3	75	2	11009421
Pubmed	Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene.	ERBB3 EGFR	1.37e-05	3	75	2	16401639
Pubmed	ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas.	ERBB3 EGFR	1.37e-05	3	75	2	25596284
Pubmed	Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.	ERBB3 EGFR	1.37e-05	3	75	2	26372697
Pubmed	Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR.	ERBB3 EGFR	1.37e-05	3	75	2	34843459
Pubmed	Dimerization drives EGFR endocytosis through two sets of compatible endocytic codes.	ERBB3 EGFR	1.37e-05	3	75	2	25588832
Pubmed	A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3.	ERBB3 EGFR	1.37e-05	3	75	2	21918175
Pubmed	DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib.	ERBB3 EGFR	1.37e-05	3	75	2	21741919
Pubmed	Mapping ErbB receptors on breast cancer cell membranes during signal transduction.	ERBB3 EGFR	1.37e-05	3	75	2	17652160
Pubmed	A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.	IKBKG TNFAIP3	1.37e-05	3	75	2	22525270
Pubmed	Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters.	CDK9 GRN	1.37e-05	3	75	2	20054825
Pubmed	Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.	ERBB3 EGFR	1.37e-05	3	75	2	18424286
Pubmed	Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers.	ERBB3 EGFR	1.37e-05	3	75	2	27405979
Pubmed	YAC clone contigs surrounding the Zfx and Pola loci on the mouse X chromosome.	POLA1 ZFY	1.37e-05	3	75	2	8406471
Pubmed	EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.	ERBB3 EGFR	1.37e-05	3	75	2	18172732
Interaction	DAB1 interactions	CUL5 ERBB3 EGFR LRP2 POGZ ITGB3	2.69e-06	107	74	6	int:DAB1
Interaction	SLC39A7 interactions	CUL5 USP49 FBN1 EGFR ESRRB GRN TRRAP	5.64e-06	187	74	7	int:SLC39A7
Cytoband	1p31	ACADM AK5	5.56e-04	21	76	2	1p31
Cytoband	10p12.31	ARMC3 KIAA1217	6.11e-04	22	76	2	10p12.31
Cytoband	11q14.3	FAT3 TRIM49C	1.30e-03	32	76	2	11q14.3
Cytoband	22q12.3	RFPL3 RFPL2	1.38e-03	33	76	2	22q12.3
Cytoband	Ensembl 112 genes in cytogenetic band chr10p12	ENKUR ARMC3 KIAA1217	1.66e-03	140	76	3	chr10p12
Cytoband	Ensembl 112 genes in cytogenetic band chr11q14	TRIM49 FAT3 TRIM49C	2.26e-03	156	76	3	chr11q14
Cytoband	17q21.32	GRN ITGB3	3.02e-03	49	76	2	17q21.32
Cytoband	Ensembl 112 genes in cytogenetic band chr14q24	ESRRB MAP3K9 LRRC74A	4.53e-03	200	76	3	chr14q24
Cytoband	Ensembl 112 genes in cytogenetic band chr22q12	RFPL1 RFPL3 RFPL2	7.07e-03	235	76	3	chr22q12
GeneFamily	Glycoprotein hormone receptors	FSHR TSHR	2.92e-05	3	57	2	199
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB3 EGFR	5.84e-05	4	57	2	1096
GeneFamily	Glypicans	GPC4 GPC6	1.45e-04	6	57	2	572
GeneFamily	Ring finger proteins	TRIM49 TRIM51 TRIM49C RFPL1 RFPL2	1.72e-03	275	57	5	58
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF597 TSHZ3 ZNF423 ZKSCAN3 ZNF30 ZFY ZNF239 ZNF71	1.76e-03	718	57	8	28
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM49 TRIM51 TRIM49C	3.35e-03	95	57	3	59
Coexpression	HAY_BONE_MARROW_STROMAL	THSD4 FBN1 HOXC10 EGFR ADAMTS9 OTOGL ZNF423 FAT3 KIAA1217 GPC4 C7	9.79e-06	767	74	11	M39209
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	PAPPA2 FLNC FBN1 EGFR ADAMTS9 POLA1 ZNF423 FAT3 KIAA1217 GPC4 C7 ALDH3B2 GPC6 PROS1	1.86e-07	773	70	14	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	thyroid gland	ISM1 LRP2 TSHR PRAG1 ITGB3 FBN3 SORCS1	1.41e-05	240	70	7	thyroid gland
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000	THSD4 PAPPA2 FBN1 HOXC10 ACADM EGFR ADAMTS9 FAT3 GPC4 LRP2 GPC6 ITGB3	3.63e-05	905	70	12	gudmap_kidney_P0_JuxtaGlom_Ren1_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	PAPPA2 FLNC FBN1 EGFR ADAMTS9 POLA1 FAT3 KIAA1217 GPC4 C7 GPC6	3.98e-05	768	70	11	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	PAPPA2 FLNC FBN1 EGFR ZNF423 FAT3 GPC6	1.19e-04	336	70	7	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	FLNC FBN1 EGFR FAT3 KIAA1217	1.25e-04	147	70	5	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	FLNC FBN1 EGFR ADAMTS9 FAT3 KIAA1217 C7	1.70e-04	356	70	7	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	PAPPA2 FLNC FBN1 EGFR ADAMTS9 FAT3 KIAA1217	1.95e-04	364	70	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_500	CUL5 HOXC10 POLA1 GPC6	2.14e-04	89	70	4	gudmap_developingKidney_e15.5_Peripheral blastema_500_k1
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000	THSD4 PAPPA2 FBN1 HOXC10 ADAMTS9 FAT3 KIAA1217 ISM1 LRP2 GPC6	2.35e-04	783	70	10	gudmap_kidney_P4_CapMesRenVes_Crym_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FLNC FBN1 EGFR ADAMTS9 ZNF423 FAT3 KIAA1217 GPC4 C7 ZRANB3	2.60e-04	793	70	10	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2	PAPPA2 ENKUR FBN1 HOXC10 ARMC3 FSHR ISM1 LRP2 MINAR1 GPC6 FBN3	2.64e-04	951	70	11	Arv_EB-LF_2500_K2
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500	THSD4 PAPPA2 HOXC10 ADAMTS9 KIAA1217 ISM1 LRP2	3.35e-04	398	70	7	gudmap_kidney_P4_CapMesRenVes_Crym_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	ZNF597 CUL5 PDS5B HOXC10 EGFR POLA1 AK5 KIAA1217 GPC6 SORCS1	3.36e-04	819	70	10	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000	PAPPA2 FLNC ENKUR FBN1 HOXC10 ARMC3 ADAMTS9 FBXL8 ISM1 C7 ITGB3	3.84e-04	994	70	11	PCBC_ratio_EB_vs_SC_1000
CoexpressionAtlas	kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_100	HOXC10 FAT3 ISM1	3.85e-04	43	70	3	gudmap_kidney_P1_CapMes_Crym_k4_100
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000	THSD4 PAPPA2 HOXC10 ADAMTS9 FAT3 ITGB3	4.10e-04	293	70	6	gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	FBN1 EGFR ZNF423 FAT3 C7	4.21e-04	191	70	5	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	PAPPA2 FLNC FBN1 POLA1 FAT3 KIAA1217 GPC6	4.49e-04	418	70	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PAPPA2 SFTPC GPC4 TEKT4 C7 SORCS1	7.97e-08	126	76	6	9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSHZ3 FBN1 EGFR GPC6 ZRANB3 WDR62	3.16e-07	159	76	6	7ed659163f45e0c4df4782997c0786900c8186c8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3AP1 EGFR ADAMTS9 GPC4 LRP2 PRAG1	3.79e-07	164	76	6	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3AP1 ARMC3 EGFR FAT3 GPC4 LRP2	6.75e-07	181	76	6	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 EGFR ZNF423 FAT3 C7 PRAG1	1.04e-06	195	76	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 EGFR GPC4 LRP2 C7 GPC6	1.07e-06	196	76	6	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 EGFR GPC4 LRP2 C7 GPC6	1.07e-06	196	76	6	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PRAG1 PROS1	1.11e-06	197	76	6	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 FBN1 ISM1 GPC4 GPC6 PRAG1	1.11e-06	197	76	6	8c728cd3c0382c4f3e4b78647b6e1447bb40ace1
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PRAG1 PROS1	1.11e-06	197	76	6	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PRAG1 PROS1	1.14e-06	198	76	6	b2d295e330772bd8e24da356c75564b4297ea9c5
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PRAG1 PROS1	1.14e-06	198	76	6	ce59ee3d970397eb62d6387699c6c6cd65457898
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PRAG1 PROS1	1.14e-06	198	76	6	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 PAPPA2 FBN1 ISM1 GPC4 GPC6	1.14e-06	198	76	6	b258f672529fb2c03e62e2696d335043c4963280
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 GPC6 PRAG1	1.14e-06	198	76	6	a699b365d3b6149f13f02b2e2ae9b6fdce761848
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PRAG1 PROS1	1.14e-06	198	76	6	3ffaea4b44067d69f954b2bd3119c88a55ab232a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	TSHZ3 ENKUR GPR156 MINAR1 ZRANB3 ZNF71	1.21e-06	200	76	6	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SFTPC KIAA1217 LRP2 GPR156 C7	4.82e-06	144	76	5	1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4\|TCGA-Lung / Sample_Type by Project: Shred V9	FBN1 ISM1 GPC6 ITGB3 MILR1	1.28e-05	176	76	5	0923b01137d6f9956ca815b41102c81e82624065
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HOXC10 ADAMTS9 FAT3 ISM1 GPC4	1.35e-05	178	76	5	8f31b3fac51591f7f2bcb898c07708b3e9f93a16
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 GPC4 GPC6 ITGB3 ZRANB3	1.39e-05	179	76	5	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	FBN1 EGFR C7 GPC6 SORCS1	1.39e-05	179	76	5	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBN1 SCUBE2 C7 GPC6 SORCS1	1.50e-05	182	76	5	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 FAT3 ISM1 GPC6 SORCS1	1.54e-05	183	76	5	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOGL FAT3 LRP2 SSPOP SORCS1	1.58e-05	184	76	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOGL FAT3 LRP2 SSPOP SORCS1	1.58e-05	184	76	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOGL FAT3 LRP2 SSPOP SORCS1	1.58e-05	184	76	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3AP1 ARMC3 EGFR ADAMTS9 GPC4	1.67e-05	186	76	5	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	THSD4 ERBB3 EGFR SFTPC KIAA1217	1.75e-05	188	76	5	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAT3 ISM1 GPC4 C7 GPC6	1.75e-05	188	76	5	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAPPA2 ISM1 GPC4 PRAG1 SORCS1	1.85e-05	190	76	5	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAPPA2 ISM1 GPC4 PRAG1 SORCS1	1.85e-05	190	76	5	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HOXC10 ADAMTS9 FAT3 GPC4 GPC6	1.89e-05	191	76	5	98b907f8fa024cf32e462323b782c5a371327bbd
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 SCUBE2 EGFR ISM1 C7	1.89e-05	191	76	5	997abf0cc5873bed0372c4a333ed307fa72774d2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 TSHZ3 FBN1 KIAA1217 C7	1.94e-05	192	76	5	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 EGFR ISM1 C7 GPC6	1.94e-05	192	76	5	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 SCUBE2 FAT3 ISM1 C7	1.94e-05	192	76	5	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 TSHZ3 FBN1 KIAA1217 C7	1.94e-05	192	76	5	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 EGFR ISM1 C7 GPC6	1.94e-05	192	76	5	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	TSHZ3 FBN1 EGFR C7 GPC6	1.94e-05	192	76	5	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 SCUBE2 FAT3 ISM1 C7	1.94e-05	192	76	5	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 SCUBE2 FAT3 ISM1 C7	1.94e-05	192	76	5	ff4b728a55c2550c806c47e9ae3d057c35df8464
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 SCUBE2 FAT3 ISM1 C7	1.94e-05	192	76	5	2d3790bd80a7f214b37094121a2a86ff16362569
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	FBN1 ZNF423 ISM1 C7 GPC6	1.94e-05	192	76	5	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 SCUBE2 FAT3 ISM1 C7	1.99e-05	193	76	5	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 SCUBE2 FAT3 ISM1 C7	1.99e-05	193	76	5	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 EGFR ISM1 C7 GPC6	1.99e-05	193	76	5	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	TSHZ3 FBN1 FAT3 C7 GPC6	1.99e-05	193	76	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	THSD4 FLNC HOXC10 EGFR FBN3	1.99e-05	193	76	5	02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC FBN1 EGFR ISM1 GPC6	2.04e-05	194	76	5	5594f7437448cb4b37d2d100f44d30c4a367df26
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TSHZ3 FBN1 FAT3 C7 GPC6	2.04e-05	194	76	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 EGFR ZNF423 FAT3 C7	2.04e-05	194	76	5	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	FBN1 EGFR C7 GPC6 SORCS1	2.04e-05	194	76	5	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 ADAMTS9 ISM1 TNFAIP3 GPC6	2.09e-05	195	76	5	841fde528ecb293e07b5e00e499d1e9f0b0dce14
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 GPC4 PRAG1 PROS1	2.09e-05	195	76	5	2514c1f23424b5fc664d326d31ffd22bafe74ef8
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HOXC10 EGFR ADAMTS9 FAT3 GPC4	2.09e-05	195	76	5	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 TSHZ3 FBN1 KIAA1217 C7	2.09e-05	195	76	5	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 SCUBE2 FAT3 ISM1 C7	2.09e-05	195	76	5	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	IPF-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	FLNC FBN1 EGFR C7 GPC6	2.09e-05	195	76	5	9c32756edb54f0c211185d9a98073fe01fd1526a
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 SCUBE2 FAT3 ISM1 C7	2.09e-05	195	76	5	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAPPA2 ISM1 GPC4 PRAG1 SORCS1	2.09e-05	195	76	5	c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAPPA2 ISM1 GPC4 PRAG1 SORCS1	2.09e-05	195	76	5	ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 TSHZ3 FBN1 KIAA1217 C7	2.09e-05	195	76	5	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 GPC4 PRAG1 PROS1	2.14e-05	196	76	5	e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 GPC4 PRAG1 PROS1	2.14e-05	196	76	5	f0fd7db22985d2bc84dc8bcbdb2d552e280121dd
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 EGFR ISM1 GPC6 PROS1	2.14e-05	196	76	5	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 EGFR ISM1 GPC6 PROS1	2.14e-05	196	76	5	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 FBN1 FAT3 C7 GPC6	2.20e-05	197	76	5	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HOXC10 ADAMTS9 FAT3 GPC4 GPC6	2.20e-05	197	76	5	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 TSHZ3 FBN1 KIAA1217 C7	2.20e-05	197	76	5	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PROS1	2.20e-05	197	76	5	9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PROS1	2.20e-05	197	76	5	090a251194da3e2806989d9a522588f83f52da7f
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPPA2 FBN1 ISM1 GPC4 PROS1	2.20e-05	197	76	5	43b5f8e917506c1717f9311584901b506ffd2c79
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 TSHZ3 FBN1 KIAA1217 C7	2.20e-05	197	76	5	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB3 GPC4 LRP2 GPC6 PROS1	2.25e-05	198	76	5	be305d89d48c67ce922fa71aaf15e24d00c89ff6
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADAMTS9 FAT3 ISM1 GPC4 GPC6	2.25e-05	198	76	5	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TSHZ3 FBN1 FAT3 C7 GPC6	2.25e-05	198	76	5	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 FBN1 FAT3 C7 GPC6	2.30e-05	199	76	5	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD4 TSHZ3 FBN1 GPC4 GPC6	2.30e-05	199	76	5	3cf62666ffd000427fdbb7cf940793f98c3ed29c
ToppCell	facs-Trachea-nan-3m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 ISM1 GPC4 GPC6 PROS1	2.30e-05	199	76	5	67f78c070c56e44fba36542041bf7fa1c291807c
ToppCell	facs-Trachea-nan-3m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 ISM1 GPC4 GPC6 PROS1	2.30e-05	199	76	5	1ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	FBN1 ZNF423 ISM1 C7 GPC6	2.36e-05	200	76	5	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	FBN1 ZNF423 ISM1 C7 GPC6	2.36e-05	200	76	5	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	THSD4 FBN1 GPC4 MINAR1 SORCS1	2.36e-05	200	76	5	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD4 TSHZ3 FBN1 GPC4 GPC6	2.36e-05	200	76	5	3dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PAPPA2 SFTPC GPC4 C7	8.17e-05	134	76	4	cb676d5bbc468bd3ce1b6712d41c986ee9221ac5
ToppCell	frontal_cortex\|World / Per Region, Lineage, Cell class, Cell type, Cell subtype	PAPPA2 FAT3 ALDH3B2 GPC6	1.33e-04	152	76	4	f9c29d4568402ca07a717dbffb3ccc7f35c5fe56
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|GI_small-bowel / Manually curated celltypes from each tissue	PIK3AP1 ENKUR LRP2 RFPL2	1.43e-04	155	76	4	1c67f58ed79331addbc012dab0cb09a7f350aedb
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ELAPOR2 LRP2 TSHR ALDH3B2	1.47e-04	156	76	4	574f761962a7dd3308bd41fc529dd3ea1b8625f8
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ELAPOR2 LRP2 TSHR ALDH3B2	1.47e-04	156	76	4	605d95a900e1443d3f6aae163ef2e893d3293203
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	THSD4 FAT3 ISM1 PRAG1	1.51e-04	157	76	4	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBN1 SFTPC FAT3 C7	1.54e-04	158	76	4	e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	THSD4 GPC6 MILR1 WDR62	1.58e-04	159	76	4	24f87c666eff10c1844c900ffd7ad49fa9f80481
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 FSHR LRP2 SORCS1	1.62e-04	160	76	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 FSHR LRP2 SORCS1	1.62e-04	160	76	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid\|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIK3AP1 GRN ARHGAP25 MILR1	1.66e-04	161	76	4	1b5ebc82ee6166ecc2984648565f334cd69b636b
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3AP1 ARHGAP4 ARMC3 TNFAIP3	1.70e-04	162	76	4	58fe827198c172eeaa26273b0fad7991a718b0bf
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	THSD4 ERBB3 GPC6 WDR62	1.70e-04	162	76	4	2259e9536147e9cdee772e3a30ba7d104573262c
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ELAPOR2 SFTPC OTOGL LRP2	1.78e-04	164	76	4	beaa13a75c3bb72446c85084d75e9fe3f15fd3d4
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ELAPOR2 SFTPC OTOGL LRP2	1.78e-04	164	76	4	d005cfd821b87548b075120bffe65a0be9860463
Computational	Placenta genes.	ARHGAP4 ERBB3 EGFR SFTPC IKBKG GRN TNFAIP3 ALDH3B2	7.52e-05	463	34	8	MODULE_38
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN3	1.66e-05	3	70	2	DOID:65 (implicated_via_orthology)
Disease	scoliosis (implicated_via_orthology)	ADAMTS9 SSPOP	5.52e-05	5	70	2	DOID:0060249 (implicated_via_orthology)
Disease	Gastric Adenocarcinoma	ERBB3 MAP3K9 TRRAP	1.69e-04	45	70	3	C0278701
Disease	mitral valve prolapse (is_implicated_in)	FBN1 TSHR	1.98e-04	9	70	2	DOID:988 (is_implicated_in)
Disease	Head and Neck Carcinoma	ERBB3 EGFR	2.47e-04	10	70	2	C3887461
Disease	gallbladder neoplasm	ERBB3 EGFR	3.01e-04	11	70	2	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB3 EGFR	3.01e-04	11	70	2	C0153452
Disease	serum dimethylarginine measurement	THSD4 ARHGAP25 GPC6	4.58e-04	63	70	3	EFO_0005418
Disease	membranous glomerulonephritis (biomarker_via_orthology)	LRP2 C7	4.96e-04	14	70	2	DOID:10976 (biomarker_via_orthology)
Disease	median neuropathy (biomarker_via_orthology)	ERBB3 EGFR	4.96e-04	14	70	2	DOID:571 (biomarker_via_orthology)
Disease	bacterial pneumonia (biomarker_via_orthology)	SFTPC ITGB3	4.96e-04	14	70	2	DOID:874 (biomarker_via_orthology)
Disease	Craniofacial Abnormalities	EGFR GPC4 LRP2 GPC6	5.25e-04	156	70	4	C0376634
Disease	cutaneous psoriasis measurement, psoriasis	USP49 TNFAIP3	6.52e-04	16	70	2	EFO_0000676, EFO_0007773
Disease	autoimmune disease	ERBB3 TSHR TNFAIP3 ITGB3	7.74e-04	173	70	4	EFO_0005140
Disease	attempted suicide	ELAPOR2 FBN1 SCUBE2 LRP2	8.61e-04	178	70	4	EFO_0004321
Disease	dilated cardiomyopathy (implicated_via_orthology)	FLNC EGFR ESRRB	9.22e-04	80	70	3	DOID:12930 (implicated_via_orthology)
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB3 EGFR	9.24e-04	19	70	2	DOID:2876 (is_marker_for)
Disease	response to methotrexate, neurotoxicity	PNPLA6 GPC6	9.24e-04	19	70	2	EFO_0011057, GO_0031427
Disease	glomerulonephritis (biomarker_via_orthology)	FBN1 ITGB3	1.03e-03	20	70	2	DOID:2921 (biomarker_via_orthology)
Disease	cortical thickness	THSD4 PDS5B ERBB3 FBN1 EGFR ADAMTS9 ZNF423 FAT3 FSHR	1.23e-03	1113	70	9	EFO_0004840
Disease	stomach carcinoma (is_marker_for)	ERBB3 TNFAIP3	1.48e-03	24	70	2	DOID:5517 (is_marker_for)
Disease	maximal oxygen uptake measurement	ESRRB TSHR	1.74e-03	26	70	2	EFO_0004887
Disease	chronic obstructive pulmonary disease (biomarker_via_orthology)	ERBB3 EGFR	2.02e-03	28	70	2	DOID:3083 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VDQTSCVRACPPDKM	ERBB3	296	P21860
ESKCPELLANYCDML	CUL5	401	Q93034
DVKCDMEVSCPDGYT	GRN	281	P28799
SPDPDVKKNSMECIY	ARMC3	161	Q5W041
EEPLMCAYCVTEPGA	ACADM	151	P11310
QTCVAPDYVLCSPEM	ALDH3B2	161	P48448
TTCLDMDECSQVPKP	FBN3	2401	Q75N90
MKCSLNPGCDEDLYE	PIK3AP1	431	Q6ZUJ8
YCMAKEDVPNDRCSA	C17orf113	136	A0A1B0GUU1
PLEYMAICALCAKDP	PDS5B	936	Q9NTI5
CEYLRPPIDCFKTMD	PNPLA6	1221	Q8IY17
LMCSKPEDPVEYLES	AK5	26	Q9Y6K8
PQGSTCCSQEMEEKY	GPC4	61	O75487
MEDGTCKVTYCPTEP	FLNC	2091	Q14315
SDKMLYCEAESPPTV	LRRC74A	41	Q0VAA2
CCPKCQYQAPDMDTL	IKBKG	396	Q9Y6K9
CGDMSDEKDCPTQPF	LRP2	1296	P98164
YCADPPLIKMACAGT	OR5M3	176	Q8NGP4
CPACMKATLQPEYSD	POLA1	1371	P09884
YIEKETNQCKECPPD	ELAPOR2	626	A8MWY0
CEAMKTNEFPSPCLD	MILR1	26	Q7Z6M3
RESCNDPCKETVPSM	PAPPA2	751	Q9BXP8
DEATCKDTCPPLMLY	EGFR	256	P00533
DYIPETDQDCSMSPC	ADAMTS9	1281	Q9P2N4
PQEYTCCTTEMEDKL	GPC6	61	Q9Y625
SCECELEGMLPPYLS	FBXL8	51	Q96CD0
MCPAVNTSEYKILCP	FBN1	1576	P35555
KMPYECGPSLDVCAQ	C7	716	P10643
EKPCPGDMQCVSYEA	FAT3	3801	Q8TDW7
MDPTCSSECIYNLIP	ENKUR	1	Q8TC29
YPPSVKEENVCCMYS	HOXC10	101	Q9NYD6
PEALENPCYDMKTTC	ITGB3	196	P05106
EPDDNSLQSPEMKCY	FOXR2	161	Q6PJQ5
MEPEINCSELCDSFP	GPR156	1	Q8NFN8
PCRKSYEDCASGIME	ESRRB	71	O95718
CSPKPDAFNPCEDIM	FSHR	346	P23945
MAKQYDSVECPFCDE	CDK9	1	P50750
TADGPECSCHPQYKM	SCUBE2	231	Q9NQ36
MNDLPSCPCSYPTEV	ISM1	316	B1AKI9
PSTCPEPFAKLMEDC	MAP3K9	371	P80192
LECEPQKFDPVYDCS	OTOGL	1471	Q3ZCN5
APGTCCYIMKIAPES	SFTPC	116	P11686
MDCKDCPQFVPASEP	MINAR1	161	Q9UPX6
EASSCPVCSDYLEKP	RFPL1	36	O75677
PVCSDYLEKPMSLEC	RFPL1	41	O75677
PLCMNYFIDPVTIDC	TRIM49	16	P0CI25
MPEEPYLQSQCDCCS	SSPOP	5091	A2VEC9
ELAEDCKRPLPCMTY	FER1L5	626	A0AVI2
LPCFEESDCKESSPM	NANOGP8	11	Q6NSW7
DTHKPGEMPYVCQVC	POGZ	581	Q7Z3K3
PKNCSVELTPDYSME	SGSM3	451	Q96HU1
MEENESQKCEPCLPY	KIAA1217	1	Q5T5P2
MAQTVPPCELPCKEY	TEKT4	1	Q8WW24
CSPLPCNEDGYMSCK	PROS1	121	P07225
YEKCMAPPSASCLGD	ARHGAP4	706	P98171
CKEMPTSENCPSFAL	ZNF30	96	P17039
SLMDVKCETPNCPFF	TNFAIP3	381	P21580
PICMNYFLDPVTIDC	TRIM51	16	Q9BSJ1
EEDTKPQGCMYLPGC	ARHGAP25	81	P42331
PLCMNYFIDPVTIDC	TRIM49C	16	P0CI26
PYCCRDMLSSLDKET	USP49	581	Q70CQ1
CPVCSDYLEKPMSLE	RFPL2	101	O75678
DYLEKPMSLECGCAV	RFPL2	106	O75678
EASSCPVCSDYLEKP	RFPL3	36	O75679
PVCSDYLEKPMSLEC	RFPL3	41	O75679
LESDYCSLMKEPAPE	PRAG1	361	Q86YV5
MCPEKELARACPSYQ	TSHZ3	46	Q63HK5
DLDCYFTPMKPESLE	WDR62	881	O43379
LENVETPMSYKCNEC	ZKSCAN3	471	Q9BRR0
SKFKPLQCPDCDMTF	ZNF597	336	Q96LX8
PMCPEQFSSVEGVYC	ZNF423	326	Q2M1K9
EKPYECEECGMSFSQ	ZNF239	316	Q16600
EEAPESYCDSSMKPT	THSD4	651	Q6ZMP0
KYAGAMESEPCVCTE	SORCS1	711	Q8WY21
PMPCEEKKTYDCSEC	ZNF71	121	Q9NQZ8
PLSPFCQFEEMKICS	TRRAP	1501	Q9Y4A5
ESEMDPCKVDSTCPE	ZFY	231	P08048
SELPYCEMCETPQGS	ZRANB3	636	Q5FWF4
MVCTPKSDEFNPCED	TSHR	396	P16473